Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
January 2026
in “
Cronfa (Swansea University)
”
TLDR Finasteride and dutasteride may increase the risk of depression and suicidality, so patients should be monitored closely.
The article investigates the association between finasteride and dutasteride, medications commonly used for hair loss, and the risk of depression and suicidality. The study emphasizes the importance of updated pharmacovigilance evidence and suggests comprehensive psychiatric assessments for individuals using these medications. The findings highlight the need for healthcare providers to be vigilant about the potential psychiatric side effects when prescribing these drugs. The authors recommend that patients be closely monitored for any signs of depression or suicidal thoughts to ensure timely intervention and support.
